Latest News and PublicationsM Tiwari et al, BIORXIV, May 1, 2020
Comparative transcriptome analysis reveals the intensive early-stage responses of host cells to SARS-CoV-2 infection
J Sun et al, BIORXIV, May 1, 2020
Inflammatory markers in Covid-19 Patients: a systematic review and meta-analysis.
G Vaseghi et al, MEDRXIV, May 2, 2020
Clinical classifiers of COVID-19 infection from novel ultra-high-throughput proteomics
CB Messner et al, MEDRXIV, May 3, 2020
Predicting community mortality risk due to CoVID-19 using machine learning and development of a prediction tool
A Das et al, MEDRXIV, May 3, 2020
Coding variants in ACE2 and TMPRSS2 are not major drivers of COVID-19 severity in UK Biobank subjects.
D Curtis, MEDRXIV, May 3, 2020
Risk prediction for poor outcome and death in hospital in-patients with COVID-19: derivation in Wuhan, China and external validation in London, UK
H Zhang et al, MEDRXIV, May 3, 2020
Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody Treatment.
Koyama Takahiko, et al. Pathogens (Basel, Switzerland) 2020 4 0. (5)
Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs.
Neogi Ujjwal, et al. Pathogens (Basel, Switzerland) 2020 4 0. (5)
Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19.
Kumar Santosh, et al. Viruses 2020 4 0. (5)
.png)
No hay comentarios:
Publicar un comentario